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ABSTRACT 
 
ANALYSIS OF LYSOSOMAL Neu4 SIALIDASE ASSOCIATED 
PROTEINS BY USING MASS SPECTROMETRY (MS/MS) 
 
Sialidases are glycohydrolytic enzymes which remove sialic acid residues from 
glycoproteins, oligosaccharides and glycolipids. There are 4 different sialidases known 
in mammalians. These are Neu1 (lysosomal), Neu2 (cytoplasmic), Neu3 (cell 
membrane) and Neu4 (lysosomal/mitochondrial) sialidase. Sialidases are involved in 
many metabolic and cellular processes interactioning with another proteins or work 
together in multiprotein complexes. For example, Neu1 is only active with beta-
galactosidase and cathepsin A enzyme in lysosome. Interactions of sialidases Neu2, 
Neu3 and Neu4 enzyme with other proteins remain unknown  
In our study, we aimed to identify proteins which have interaction with sialidase 
Neu4 as well as Neu1 by using mass spectrometry analysis to find new possible roles of 
sialidases. Our bait protein's cDNA was tagged with calmodulin binding protein as well 
as streptavidin binding protein. After transfection and expression of vectors to 
mammalian cells, proteins were purified using  tandem affinity purification (TAP). We 
identified some associated proteins with sialidase Neu1 and Neu4 by using MS/MS 
analysis and bioinformatics. 
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ÖZET 
 
LİZOZOMAL Neu4 SİALİDAZIN ETKİLEŞİME GİRDİĞİ 
PROTEİNLERİN KÜTLE SPEKTROMETRİSİ (MS/MS) İLE ANALİZİ 
 
Sialidazlar glikoproteinlerden, oligosakkaritlerden, ve glikolipitlerden sialik asit 
gruplarını uzaklaştıran glikohidrolazlardır. Memelilerde 4 adet sialidaz karakterize 
edilmiştir. Bunlar Neu1 (lizozomal), Neu2 (sitoplazmik), Neu3 (hücre membranı), Neu4 
(mitokondriyel/lizozomal) sialidazdır. Sialidazlar birçok metabolik yolakta ve hücresel 
işleyişlerde rol almaktadır. Sialidazlar başka proteinlerle ilişki kurabilir ya da multi-
protein kompleksleri oluşturarak  beraber çalışabilir. Örnek olarak, Neu1 hücrede beta-
galaktosidaz ve katepsin A enzimi ile beraber lizozomda aktiftir. Diğer Neu2, Neu3 ve 
Neu4 sialidaz enzimlerinin proteinlerle ilişkileri tam olarak tanımlanamamıştır. 
Çalışmamızda lizozomal Neu4 enziminin ve yanında Neu1 enziminin ilişkili 
olduğu proteinleri kütle spektrometrisi ile belirleme ve sialidazların yeni rollerini 
bulmak amaçlandı. Proteinimizin cDNA'sı kalmodulin bağlanma bölgesi ve streptavidin 
bağlanma bölgesi ile işaretlendi. Anlatım vektörü memeli hücrelerine transfeksiyon 
yapıldıktan sonra sıralı afinite saflaştırması ile proteinler saflaştırıldı. Sonuç olarak 
çalışmamızda sialidaz Neu4 ve Neu1 ile ilişkili olan proteinleri, MS/MS ve 
biyoinformatik analizleri kullanarak tanımladık. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
1.1. Sialidases 
 
Sialidases (EC 3.2.1.18), also known as neuraminidases, are glycohydrolatic 
enzymes which remove sialic acid residues from glycoproteins (mucin), 
oligosaccharides (siallylactose) and glycolipids (GD1a) (Saito and Yu et al. 1995) 
(Figure1.1). Sialidases are found in all organisms such as virus, bacteria, protozoa and 
vertebrate (Saito and Yu et al. 1995). Sialidases have roles in metabolic pathways like 
cell proliferation, adhesion, differentiation, membrane fusion and fluidity, catabolism of 
gangliosides and glycoproteins (Saito and Yu et al. 1995). Substrates which carry sialic 
acid residues can affect and induce metabolic pathways when these residues were 
degraded by sialidases. (Miyagi et al. 2008). 
 
 
Figure 1.1. GD1a molecule carries sialic acid (SA) residues. 
 
In mammals, 4 different sialidases were identified according to subcellular 
distribution, substrate specificity and stability. These sialidases are lysosomal Neu1 
(Bonten et al. 1996), cytosolic Neu2 (Monti et al. 1999), plasma membrane Neu3 
(Monti et al. 2000) and lysosomal or mitochondrial membrane Neu4 (Monti et al. 
2004). Human sialidases contain conserved F/YRIV/P  (-Phe (Tyr)-Arg-Ileu-Val (Pro)-) 
motif and Asp boxes  (–Ser–X– Asp–X–Gly–X–Thr–Trp–)  in the N-terminal part of 
the enzyme (Roggentin et al. 1993). 
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Sialidase expression in cells is lower than other genes and detection of sialidases 
in tissues is difficult when compared to other proteins (Minami et al. 2011). Neu1 has 
the highest expression level in cells about 10- 20 times higher than Neu3 and Neu4. 
Neu2 has extremely low expression (Hata et al. 2008). Neu1 shows low homology to 
other sialidases (nearly 19-24 % homology) but Neu2, Neu3 and Neu4 have 34-40 % 
homology when compared to each other. 
 
1.1.1. Neu1 
 
Neu1 is the lysosomal sialidase which is expressed from NEU1 on human 
chromosome 6p21.3, locus of the major histocompatibility complex (Bonten et al. 
1996). Neu1 is 43-46 kDa protein and locates on lysosomal membrane, lysosomal 
lumen, cell membrane as an integral membrane protein (Lukong and Seyrantepe et al. 
2001). It is also found in vesicular traffic system (Vinogradova et al. 1998). It is 
ubiquitously expressed in vertebrate cells with the highest expression levels in the 
kidney, pancreas, skeletal muscle, liver, lungs, placenta and brain (Bonten et al. 1996). 
One of the well-known  lysosomal multienzyme complex composing of Neu1 is β-
galactosidase (β-GAL) and Cathepsin A protein complex (Bonten et al. 2009). 
Sialidase Neu1 removes sialic acid residues from glycoprotein and glycolipids 
(Pshezhetsky et al. 2001). Deficiency in NEU1 causes metobolic disorder called 
sialidosis and accumulation of sialylated oligosaccharides are observed in lysosomes of 
sialidosis patients (Thomas et al. 2001). Neu1 also has role in immune response which 
causes monocyte differentiation by transporting to the cell membrane from lysosome 
(Liang and Seyrantepe et al. 2006). Furthermore Neu1 initiates signal pathways by 
removing sialic acid residues from  receptors like insulin, TOLL-like receptor (Figure 
1.2) and regulates metabolic processes (Arabkhari et al. 2010; Stamatos et al. 2010; 
Amith et al. 2009). 
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Figure 1.2. Interactions of Neu1 in cellular pathways. TLR: TOLL like receptor, 
LAMP: Lysosomal-associated membrane protein, IR: Insulin receptor, 
IGF-1R: Insulin growth factor 1 receptor, FcRy: fc receptor-related protein 
Y (Adapted from Alexey V. Pshezhetsky et al. 2010). 
                   
1.1.2. Neu2  
 
Neu2 is cytosolic sialidase which is expressed on human chromosome 2q37.  It 
was isolated from rat skelatal muscle by cDNA analysis as a mammalian sialidase 
(Miyagi et al. 1993). Neu2 locates on cytoplasma and has an activity on glycopeptides 
and gangliosides and mostly expressed in muscle cells in human. (Miyagi and Tsuiki et 
al. 1985; Monti et al.1999; Tringali et al. 2004). The human NEU2 gene up-regulation 
in leukemic K562 cells (human myelogenous leukemia) induced a marked decrease in 
anti-apoptotic factors Bcl-XL and Bcl-2 (Tringali et al. 2007). 
 
1.1.3. Neu3 
 
Neu3 is known as a membrane sialidase and is expressed on human chromosome 
11q13.5. It has a role in caveolar domain of membrane (Wada et al. 1999, Wang et al. 
2002). Neu3 affects ganglioside's oligosaccharide composition on the cell membrane. 
Neu3 also initiates induction of cell transformation, differentiation and formation of cell 
interactions (Kopitz et al. 1996;  Kopitz et al. 1998). 
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1.1.4. Neu4 
 
Neu4 is lysosomal/mitochondrial sialidase and is expressed from telomeric 
region of the long arm of human chromosome 2q37. Sialidase Neu4 enzyme has two 
isoforms which are generated by alternative splicing (Figure 1.3). Short form contains 
484 amino acids (Monti et al. 2004) and long form containing 496 amino acids (Bigi et 
al. 2010). Mouse Neu4 has two isoforms Neu4a and Neu4b (Shiozaki, Koseki et al. 
2009). It has a F/YRVP sequence motif in N terminal site and Asp boxes downstream. It 
is shown that Neu4 localizes on lysosomes (Seyrantepe et al. 2004), mitochondria 
(Yamaguchi et al. 2005) and endoplasmic reticulum, (Bigi et al. 2010). The long form 
of Neu4 carries additional 12 amino-acid sequence on N-terminal and it is predicted to 
be a mitochondrial sorting signal (Yamaguchi et al. 2005). Mannose 6-phospate tagging 
directs Neu4 to lysosome (Monti et al. 2004). Neu4 is active in acidic pH and degrades 
gangliosides suggesting that it is a lysosomal enzyme and it locates lysosomes although 
Neu4 sialidase enzymes carry any signal on neither C terminal nor N terminal of amino 
acid sequence. However  it was observed that long form of Neu4 locates on 
mitochondria , short form locates on endoplasmic reticulum (Bigi et al. 2010). 
 
 
Figure 1.3. Human Neu4 sialidases isoforms  
(Source: Yamaguchi et al. 2005) 
 
Neu4 is ubiquitously expressed in human brain, colon, small intestine, kidney, 
heart, skeletal muscle. Human Neu4 sialidase enzyme has the highest expression level 
in liver. Mouse brain has the highest expression level of Neu4 sialidase compared to 
other tissues and organs (Comelli et al. 2003). Synthetic substrates 2'-(4-
methylumbelliferyl)-alpha-D-N-acetylneuraminic acid (4-MU-NANA or 4MU-NeuAc) 
can be degraded by Neu4 sialidase (Monti et al. 2004). Murine Neu4 sialidase 
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hydrolyses polysialic acid residues efficiently degrading oligoSia and polySia chains as 
substrates in vitro (Takahashi et al. 2012). 
Neu4 sialidase shows optimum activity in acidic pH and degrades GM1, GM2 
and GD1a gangliosides in vitro (Figure 1.4). Overexpression of sialidase Neu4 converts 
lysosomal storage in human skin fibroblasts which have deficiency of lysosomal Neu1 
sialidase. (Seyrantepe et al. 2004). It means Neu4 sialidase is biologically active 
enzyme and can be useful for novel therapeutic purposes such as in sialidosis and 
galactosialidosis.  
 
 
Figure 1.4. Degredation GD1a to GM1 by sialidase activity 
 
It was observed that Neu4 knocked-out mouse has decreased GM1 and increased 
GD1a levels in brain tissue (Seyrantepe et al. 2008). Neu4 sialidase and HexA 
(hexaminidase A) knock-out mouse showed abnormal behaviors like epileptic seizures, 
rapid neuronal loss and accumulation of ganglioside GM2 (Seyrantepe et al. 2010). 
Neu4 has a role in degradation of gangliosides in mouse. 
Expression of Neu4 decreases in macrophage differentiation (Stamatos et al. 
2005). In human colon cancer cells Neu4 has low expression levels and overexpression 
of Neu4 induced apoptosis causing reduced invasiveness and motility (Miyagi et al. 
2008). Neu4 acts on Sialy Lewis antigens, known as a colon cancer marker, and 
decreases level of Sialy Lewis antigens (Kazuhiro et al. 2011). Expression of long form 
Neu4 is dramatically down-regulated in the early course of apoptosis. On the other 
hand, overexpression of  long Neu4 activates neuroblastoma proliferation via Wnt/β 
catenin signal pathway (Tringali et al. 2012). Thymoquinone induced Neu4 activate 
NFκB activation via G-protein coupled receptor (GPCR) and matrix metalloproteinase 
(MMP) protein complex (Finlay et al. 2010)  
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1.2.Tandem Affinity Purifications (TAP) 
 
Detection of complex protein-protein interactions are important to understand 
biological processes in cells. Co-immunoprecipitation method can be with two-hybrid 
studies to detect proteins which interact each other. However it does not give 
information about proteins complexes with more than two proteins. To detect protein 
complexes in yeast, another technique was developed (Puig et al. 2001; Rigaut et al. 
1999). Tandem affinity purification (TAP) provides us to detect associated protein 
complexes by using special tag which is added to protein amino acid sequence and we 
can detect proteins using mass spectrometry analysis. Two or more tags are added to 
DNA sequence that express bait protein. Furthermore  protein and its complex are 
purificated by affinity steps gently with non-disrupted  protein complex . Two tags are 
sufficent to elute protein and its complexes furthermore the method allow clean 
purification.  
 
1.2.1. Interplay Mammalian Tandem Affinity Purification System 
 
TAP system for mammalian cell (Braman et al. 2007) was developed to purify 
protein complex using affinity of Streptavidin Binding Peptide and Calmodulin Binding 
Peptide (Figure 1.5). 
Streptavidin binding peptide (SBP, 4,91 kDa) which shows high affinity to 
streptavidin resin and can be eluted with biotin (Wilson et al. 2001; Keefe et al. 2001). 
Calmodulin binding peptide (CBP, 2,96 kDa) which shows high affinity to calmodulin 
resin in calcium solution and removing of calcium from environment releases protein 
complex from calmodulin resin via chelating agent. SBP and CBP are useful for tandem 
affinity purification and can be attached to proteins and these proteins can be eluted 
easily using only affinity without protease digestion (Figure 1.6).  
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Figure 1.5. Bait protein with calmodulin binding peptide, streptavidin binding peptide  
                   and associated protein in cell (Adapted from Agilent website) 
 
First purification step is very important because mammalian cells include a lot of 
contaminant which has interactions with CBP and these proteins can be purified if we 
choose Calmodulin resin purification. 
 
 
Figure 1.6. Streptavidin Binding Peptide (SBP; 4,91 kDa) and Calmodulin Binding  
                  Peptide (CBP; 2,96 kDa) (Adapted from Agilent Kit Manual) 
 
1.3. Mass Spectrometry (MS) Analysis 
 
Molecules have different molecular weights and ionic charges. MS is based on 
weight/charge ratio of molecules because MS measures this ratio. MS is powerful 
technique to determine molecules and can determine sample composition, compounds 
and its shape, and also post-translational modifications such as phosphorylation, 
methylation, acetylation, and ubiquitination. Complex protein mixtures and purifed 
proteins can be detected by using different MS analysis depending on the studies and 
proteins can be identified after database searching of MS results (Figure 1.7). 
Molecules must be in ionic form to be analyzed in MS. MS instrument includes 
ionizer, mass analyzer and mass detector. When MS/MS is applied, results give us our 
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proteins' fragments which is amino acid sequence depending on charge and molecular 
weight. 
Ionized molecules are turned in gas form in ionizer module and sent to mass 
analyzer which have magnetic field. ESI (Electro Spray Ionization) and MALDI (Matrix 
Assisted Laser Desorption-Ionization) techniques are used (Domon and Aebersold et al. 
2005) to produce ions.  
Mass analyzers separate peptides depending on their molecular weight/charge 
ratio. If more than one mass analyzer is used, result is named as MS/MS and gives 
detailed amino acid sequence of interested protein (Domon and Aebersold et al. 2005). 
Quadrupole, ion traps, orbitraps, fourier transform ion cyclotron resonance (FTICR) and 
time of flight (TOF) are the mass analyzers. 
FTICR and orbitraps do not have ion detector. Ions hit detector and ion detector 
give some peaks as a signal depending on molecular weight/charge ratio. Secondary 
electron multipliers (SEMs) and 18 microchannel plate (MCP) detectors are the most 
common ion detectors (Dubois et al. 1999). 
 
 
Figure 1.7. Processes to prepare a sample for mass spectrometry analysis and 
identification; 2-DE: two-dimensional electrophoresis; LC: liquid 
chromatography; n-D: ndimensional; db: database; MS: mass 
spectrometry; PMF: peptide mass fingerprint; PTM: post-translational 
modification (Source: Schlüter et al. 2009). 
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1.4. Aim of the Project 
 
Our aim is to identify lysosomal Neu4 as well as Neu1 sialidase associated 
proteins by MS/MS analysis and find possible new roles of Neu4 sialidase in cellular 
events. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1. RNA Isolation and cDNA Synthesis 
 
Total RNA was extracted from human fibroblast cell line using Trizol reagent 
(Invitrogen). Isolated RNA was used in RT-PCR for cDNA synthesis (Fermentas). 
Lysosomol Neu4 sialidase was amplified  with forward primer containing EcoRI 
restriction site (5'-GAATTCCATGATGAGCTCTGCAGCCTTC-3') and reverse primer 
containing XhoI restriction site (5'-CTCGAGGGAGGGCCAGCAGCACCCCCGA-3') 
by DNA polymerase (NEB) removing stop codon on Neu4 sialidase cDNA. 
 
2.2. TA Cloning  
 
After PCR amplification, samples were run in 0,8% agarose gel and purified 
using Genejet Gel Extraction Kit (Fermentas, K0513). Purified 1,6 kb lysosomal  Neu4 
cDNA fragment was cloned into TA cloning vector (Invitrogen) (Figure 2.1) using 
Dh5α E.coli strain. Transformant cells were selected using blue-white screening. White 
colonies were cultured in LB-Broth medium containing 100 mg/ml kanamycin at 37 °C 
overnight in shaker incubator. Plasmids were isolated using alkaline lysis protocol and 
digested by EcoRI and XhoI enzyme at 37 °C for confirmation.  
Cloned TOPO plasmids were sequenced at Izmir Institute of Technology, 
Biotechnology and Bioengineering Research and Application Center as a service 
provider by different fluorescent dye labelled dideoxynucleotide chain terminating 
method. Using M13 primer and T7 primer. The sequences obtained from the sequencer 
were analysed using BLAST (Basic Local Alignment Search Tool). 
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Figure 2.1. pCR 2.1 TOPO vector 
 
 
2.3. Propagation of pCTAP-A and pCTAP-B Vector 
 
Interplay Mammalian TAP Kit (Agilent) provided us 3 kinds of expression 
vectors named as pCTAP-A, pCTAP-B and pCTAP-C. pCTAP-B vector (Agilent) was 
suitable for protection of  Neu4 cDNA frame and pCTAP-A for NEU1 cDNA frame 
preventing frame-shift mutations so they were propagated with PureLink™ Plasmid 
DNA Purification Kit (Midiprep, Invitrogen, K2100-04) and confirmed using Hind3 
enzyme (Fermentas). Vector was confirmed using HindIII enzyme at 37 °C overnight 
and loaded on 1% agarose gel. 
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2.4. Cloning of NEU4 cDNA into pCTAP-B Vector and NEU1 into 
       pCTAP-A 
 
To enhance cloning efficiency, we prepared double digestion for sticky ends at 
the ends of the vectors and inserts. TOPO-Neu4 and PCTAP-B vectors (Figure 2.2) 
were double digested using EcoRI and XhoI enzyme. Enzyme units and buffer selection 
were determined as a recommendation of Fermentas Double Digestion Tool 
(http://www. fermentas.com/en/tools/doubledigest). After 2 hours digestion at 37 °C, 
digestion mixture loaded on 0,8% agarose gel and run. Neu4 cDNA and pCTAP-B 
vector with sticky ends, were purified by Genejet Gel Extraction Kit (Fermentas).  
 
 
Figure 2.2. pCTAP Vector : In pCTAP-A, no bases inserted; in pCTAP-B, A inserted;     
                  in pCTAP-C, AA inserted on arrowed site. 
 
 
 
13 
 
Concentrations of samples were measured with nanodrop (NanoDrop 
Technologies, Inc. ND-1000 spectrophotometer). Purified and double digested Neu4 
cDNA and pCTAP-B were ligated with T4 DNA Ligase (Invitrogen, 15224-017) 
according to manufacturer’s instructions. 
After ligation 1 µl of ligation mixture were transformed into chemically 
competent Dh5α E.coli cells using heat shock method. Cells were plated on 50 mg/ml 
kanamycin LB-Agar plates and incubated at 37 °C for 16 hours. Following day, 
transformant cells were selected and inoculated in 50 mg/ml kanamycin LB-Broth. 
After overnight incubation, plasmid purification was performed using alkaline lysis 
method.  Plasmid was confirmed by double digestion method with EcoRI and XhoI 
restriction enzymes at 37 °C for 2 hours and digestion mixture was run on 1% agarose 
gel. Later, we prepared large scale inoculation in 500 ml LB-Brotth containing 50 
mg/ml kanamycin at 37 °C for 16 hours. After incubation, plasmids were purified by 
plasmid purification kit (PureLink™ HiPure Plasmid Filter MaxiPrep Kit K210017 
(Invitrogen)). 
 
2.5. Transfection Reagent Polyethylimine (PEI) 
  
PEI is a cationic lipid and it can be used as a lipid based transfection reagent. It 
has affordable price and has a great transfection efficiency. It is also less cell toxic when 
compared to other reagents. PEI is prepared as 1 mg/ml stock solution with sterile 
distilled water and stored at -20 °C. It remains fresh and  does not lose transfection 
efficiency more than 1 year at -20 °C pH must be  between 6,4-7,0.  
 
2.6. Optimization of Transfection with pEGFP-N2 (Green Fluorescent  
       Protein)  
 
COS7 (African green monkey kidney cell line) cells were cultured in T25 flasks 
in MEM which includes 10% FBS, 1% 1X  non-essential amino acid, 1% 
streptomycin/penicillin (100 unit)  and inoculated to 6 well plates. Cells were grown up 
until they reach about 80% confluency. Transfection were performed with "blank 
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MEM" that does not contain FBS, amino acids and antibiotics. Medium was changed at 
transfection time with blank MEM. 1 ml blank MEM was used for 6 well plate. 
Polyethylimine (PEI 1 mg/ml) was used as a transfection reagent and pEGFP-N2 
vector was transfected to COS7 as well as HeLa cell lines. Different ratios of DNA:PEI 
were tested on COS7 cells (1:1, 1:2, 1:3, 1:4, 1:5 and mock control). Vector DNA and 
PEI were added into 100 µl of 150 mM NaCl solution seperately and both mixtures 
were incubated for 10 minutes at room temperature. NaCl solution was used to enhance 
transfection efficiency. PEI is cationic lipid and NaCl solution serves best condition to 
make complex with DNA for PEI. PEI in NaCl solution was combined with vector 
DNA in NaCl solution preventing DNA loss and incubated for 15 minutes at room 
temperature. Mixture was drop wised to blank medium of cells and gently shaken.  
Cells were incubated for 3 hours at 37 °C, 5% CO2. After 3 hours MEM 
including only 10% FBS was added into cells in the same quantity with blank MEM. 
Cell were incubated for 3 hours additional and medium was changed with MEM 
including 10% FBS, 1X amino acids, 1% penicillin-streptomycin. GFP flourescence 
was visualized under flurorescent microscope after 24 hours. The best transfection 
efficiency was achieved with 1:3 ratio of  DNA:PEI, respectively (3µg DNA with 9 µl 
PEI (1 µg/µl)). Optimization of large scale transient transfection which was performed 
with a 150 mm cell culture dish and 72 µg of DNA in the same ratio was used.  
 
2.7. Transfection of COS7 Cells and Protein Purification for Western   
       Blot Optimization 
 
After optimization of transfection, we transfected our construct, pCMV-NEU1 
which was used in previous study, to COS7 cells to confirm expression of vectors in 6 
well plate using western blotting. After 48 hours of transfection, cells were collected 
and washed with cold PBS 3 times. Cells were gently mixed with lysis buffer including 
protease inhibitor coctail (Sigma) and Phenylmethanesulfonyl fluoride (PMSF, Sigma) 
and lysed using freeze and thaw technique 3 times. Cells were frozen at -80 °C and 
thawed on ice. Lysate was centrifuged on 14.000 rpm for 10 minutes at 4 °C. 
Supernatant was collected, aliquated  and stored at -80 °C. 
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2.8. Quantification of Protein Amount 
 
We used Bradford Assay to determine protein concentration. Firstly we prepared 
different BSA concentrations ranging between 10 and 200 µg/ml to draw standard 
graphic for absorbance-protein concentration diluted isolated proteins with Bradford 
solution in ratio of 1:10. Absorbance was measured at 520 nm wavelenght and protein 
concentrations were determined using standart graphic. 
 
2.9. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis      
       (SDS-PAGE) and Western Blotting 
 
First we optimized western blot protocol in our laboratory then we detected our 
expressed Neu1 proteins using western blot technique. We prepared SDS-PAGE gel to 
run and separate our proteins. We prepared 6% upper gel and 10% resolving gel (dH20, 
upper buffer or resolving buffer, %30 Acrylamide (Sigma), 10% SDS (Applichem), 
TEMED (Sigma) , 10% APS (Applichem)). 20 µg protein mixture was mixed with 
protein loading dye and heated at 90 °C at 5 minutes. Protein mixture was loaded on gel 
and run 6 hours at 60 V as vertical electrophoresis in running buffer (0.25M Tris, 1,92 
M Glycine, 1% SDS (w/v)).  
Another gel was prepared to stain proteins with 1 mg/ml Coomasie Blue 
(Sigma), 10% acetic acid, 30% methanol or ethanol. Gel was incubated in Coomasie 
Blue for 1 hour and incubated in the same solution without Coomasie Blue to visualize 
protein bands in order to confirm whether lysis method was worked or not. 
After electrophoresis, gel was placed between whatmann sheet and 
nitrocellulose membrane. Nitrocellulose membrane was activated in transfer buffer 
(48mM Tris, 39mM Glycine, 20% ethanol (v/v), 1L dH2O).  
Proteins were transfered to nitrocellulose membrane (Roche) at 60 V for 3 hours. 
Membrane was tested using Ponceau S (Sigma) dye and washed ultrapure water and 
washing buffer (1X PBS, 0.05% Tween20 ). 
Membrane was blocked with blocking buffer (1X PBS, 0.05% Tween20, 0,5% 
non-fat dry milk) for 1 hour at room temperature. After blocking, membrane was 
incubated with washing buffer including 10% blocking buffer with anti-NEU1 (Santa 
Cruz Antibodies ) and beta-actin primer antibodies (1:5000) in different containers for 1 
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hour and shaking gently. Membranes were washed 6 times with washing buffer for 5 
minutes each  and membrane was incubated in washing buffer including 10% blocking 
buffer with anti-rabbit HRP (Horseradish peroxide) seconder antibody (Santa Cruz 
1:2000) for 1 hour and shaking gently. Membranes were washed 6 times for 5 minutes 
each. After last washing, 500 µl enhanced chemiluminescent substrate for HRP 
(Thermo) and 500 ul enhancer solution (Thermo) were spread on membrane and 
incubated for 2 minutes. Membranes releasing chemiluminescence were visualized 
using VersaDoc Imager in Izmir Institute of Technology, Biotechnology and 
Bioengineering Research and Application Center.  
 
2.10. Detecting Recombinant Proteins using Western Blotting 
 
We transfected our constructs pCTAP-A-NEU1 and pCTAP-B-NEU4 to COS7 
cells in 6 well plates to detect their expressions. Cells were lysed and total protein 
extract was collected. 20 µg of protein was loaded on SDS-PAGE and transfered 
nitrocellulose membrane using electroblotting. Although Neu4 antibody commercially 
is available, it is not trustworthy. Therefore we used anti-NEU1 antibody to detect 
recombinant Neu1 and anti-calmodulin antibody (Upstate, Milipore 1:5000) to detect 
recombinant Neu4. Anti rabbit-HRP (Horseradish peroxide) antibody was used as a 
seconder antibody. Membranes were visualized using VersaDoc Imager in Izmir 
Institute of Technology, Biotechnology and Bioengineering Research and Application 
Center. 
 
2.11. Transfection for Tandem Affinity Purification 
 
Since 1x10
8
 cells were required we cultured COS7 and HeLa cells in 150 mm 
culture dishes in 10 replicas for each TAP transfection. Cells were passaged one day 
before the experiment to maintain 80-90% confluency. Cells were transfected with 
expression vectors pCTAP-A-NEU1 and pCTAP-B-NEU4 using optimized method 
with 72 µg DNA for 1 culture dish and mock-transfected cells were used as control. 
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2.12. Purification of Bait and Associated Proteins 
 
Cells were washed with cold PBS 3 times and scaled-up, pooled, and processed 
concurrently on ice after 48h post transfection. Cells were lysed with lysis buffer 
(provided by Agilent) using freeze and thaw technique. Proteins (Figure 2.3) were 
purified using Interplay Mammalian Tap System according to manufacturer’s 
instructions using calmodulin and streptavidin affinity of tagged protein (Figure 2.4) 
and stored at -20 °C for further mass spectrometry analysis. 
 
 
 
 
Figure 2.3. Schematic presentation of tagged Neu1 (53 kDa) and Neu4 (60kDa) protein 
 
 
 
 
Figure 2.4. Schematic presentation of purification steps of tagged Neu1 and Neu4   
                   protein. 
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2.13. MS/MS Analysis 
 
We made collaboration with Dr. Ahmet Tarık Baykal from Gene Engineering 
and Biotechnology Institute, TUBITAK-MAM and Prof. Dr. Talat Yalçın from IYTE 
Mass Spectrometry Laboratory. 
Purified proteins from transfected COS7 cells were analysed in TUBITAK-
MAM. First, proteins were concentrated using dialysis method overnight ( 3-7 IDa cut 
off). Uncolored mixture was centrifuged at 15000 rcf for 10 minutes. Concentration of 
proteins were measured using bradford reagent. 50 µg protein was added into test  tube 
and added dH2O to make volume 50 µl. Mixture was incubated at 80 °C for 15 minutes. 
100 mM DTT (Dithiothreitol) dissolved in 50 mM ammonium bicarbonate, was added 
and incubated at 60 °C for 15 minutes. 200 mM IAA (Iodoacetamide) dissolved in 50 
mM ammonium bicarbonate, was added and incubated at room temperature in dark. 1 
µg of trypsin, dissolved in 50 mM ammonium bicarbonate (1:50) was added and 
incubated at 37 °C overnight.  
500 ng of trypsinized  peptides were used for analysis in the presence of 2 ul 
TFA (Trifluoroacetic acid) and 2 µl ACN (Acetonitril). HDMS (High Definition Mass 
Spectrometry) and nano Acquity UPLC (Ultra-High Performance Liquid 
Chromatography) system were used to prepare samples for MS/MS. Control protein 
was added to mixture as a positive control like enolase yeast protein. These peptides 
were separated using acetonitril gradient (5-40%) for 90 minutes and using 1D-reverse 
phase separation. Finally, samples were analysed in ESI-MS/MS to detect protein 
composition (Figure 2.5).  
Purified proteins from transfected HeLa were analyzed in IYTE Mass 
Spectrometry Laboratory. Proteins were run into non-linear (pH gradient : 3-10) strip. 
Strip was loaded to SDS-PAGE gel for 2-dimensional gel electrophoresis. Proteins were 
run into gel for 5 hours. Polyacrylamide gel was incubated in Coomassie solution and 
incubated for 16 hours at 4 °C and washed with water. Gel was incubated in destaining 
solution for 2 hours. Protein dots were cut from gel and washed. Proteins were 
trypsinized overnight. Peptides were zip tipped and loaded on matrix before MALDI-
TOF analysis. 
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Figure 2.5. In-solution trypsinization of proteins and downstream process of MS/MS  
(Adapted from Gucek 2012) 
 
2.14. Bioinformatic Analysis 
 
Dr.Tarık Baykal processed MS/MS data using bioinformatic in PGLS 
(ProteinLynx Global Server) . Also "PKL" data were analyzed by using Mascott 
programme and searched in protein database (Swissprot) to find releated protein 
candidates according to peptide composition which was purified by TAP system. HeLa 
proteins were analyzed by using Mascott programme in IYTE Mass Spectromety 
Laboratory.  
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CHAPTER3 
 
RESULTS 
 
3.1. Cloning, Confirmation by Restriction Enzymes and Sequence  
       Analysis 
 
Human Neu4 cDNA was cloned into pCTAP-B vector and purified by using 
miniprep plasmid purificaion kit (Fermentas). pCTAP-B-NEU4 and previous prepared 
pCTAP-A-NEU1 were confirmed by double digestion with EcoRI and XhoI restriction 
enzymes, also with NotI and BamHI retriction enzymes. Confirmation was also 
performed with KpnI (Figure 3.1, Figure 3.2).  
 
 
                             
Figure 3.1. Agarose gel electrophoresis of double digestion of pCTAP-A-NEU1 with 
                  NotI-BamHI. 1) 1 kb DNA marker. 2) Gel image indicates 4.5 kb fragment 
                  of pCTAP-A vector and 1.2 kb fragment of Neu1 cDNA.  
 
 
 
 
 
1 2 
pCTAP-A  4.5 kb 
Neu1 cDNA kb 1.2 kb 
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Neu1 and Neu4 DNA were sequenced in Izmir Institute of Technology, 
Biotechnology and Bioengineering Research and Application Center and neither DNA 
polymerase error nor stop codons were detected (Figure 3.3). We used KpnI enzyme 
digestion to make additional confirmation (Figure 3.4). 
 
 
 
Figure 3.3. Sequence Analysis of pCTAP-B-Neu4 showing no-stop codon. 
 Figure  3.2. Agarose gel electrophoresis of double digestion of pCTAP- B-NEU4 with  
EcoRI-XhoI 1) 1 kb DNA ladder , 2) Gel image indicates 4,5 kb fragment 
of pCTAP-B and 1,5 kb Neu4 cDNA. 
pCTAP-B  4.5 kb 
Neu4 cDNA  1.5 kb 
1 2 
22 
 
 
                
Figure 3.4. Agarose gel electrophoresis of KpnI digestion of pCTAP-A-NEU1 and 
pCTAP-B-NEU4. 1) 1kb DNA ladder 2-3) KpnI digestion of pCTAP-A-
NEU1 cuts insert and vector and gel image indicates ~5,5 kb and 0,25 kb 
DNA bands 4-5) Confirmation of pCTAP-B-NEU4 with KpnI enzyme, 
KpnI enzyme cuts insert and vector and gel image indicates ~5kb and 1,1 
kb DNA bands. 
 
3.2. Optimization of Transfection 
 
pEGFP-N2 vector was used to optimize transfection. The best transfection 
efficiency was observed with 1:3 ratio of DNA:PEI. GFP was visualized by fluorescent 
microscope and cells that expressed GFP were observed (Figure 3.5). 
 
 
 
Figure 3.5. Transfection Optimization. A :  Transfected COS7 cells (up) and HeLa cells 
(down) under fluorescent light. B : Same area of COS7 and HeLa cells 
under white light. 
1 2 4 5 3 
5,5 kb 
5 kb 
1,1 kb 
0,25 kb 
A B 
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3.3. Optimization of Western Blotting 
 
To optimize Western Blotting we used proteins from non-transfected COS7 cells 
(Figure 3.6) as well as pCMV-NEU1 and pCTAP-A-NEU1 transfected COS7 cells 
(Figure 3.7). We used anti-Neu1 (Santa Cruz), anti-beta actin (Santa Cruz) antibodies. 
 
 
                 
 
 
Figure 3.6. Detection of endogenous Neu1 protein in COS7 (1) and HeLa (2) cells  by 
Western Blotting 
 
 
 
 
                
 
 
Figure 3.7. Detection of tagged Neu1 protein in COS7 cells  by Western Blotting. Neu1 
expression of pCMV-NEU1 (1) and pCTAP-A-NEU1 (2) in COS7 cells. 
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3.4. Western Blotting Analysis of Purified Tagged Proteins 
 
Transfected COS7 cells were lysed and total protein purification was performed. 
Expression of pCTAP-A-NEU1 was detected with anti-calmodulin epitope tag antibody 
(Upstate, Millipore) and anti-Neu1 antibody (Santa Cruz). Expression of pCTAP-B-
NEU4 and pCTAP-A-NEU1 were detected using anti-calmodulin epitope tag antibody 
(Figure 3.8, Figure 3.9). 
 
                   
       
Figure 3.8. Detection of tagged proteins using anti-calmodulin epitope tag antibody 1) 
Expression of Neu4+SBP+CBP, 60 kDa 2) Expression of Neu1+SBP+CBP, 
53 kDa    3) Mock transfected control 
 
 
 
                                             
                                             
Figure 3.9. 1) Detection of expression of pCTAP-A-NEU1 with anti-Neu1 antibody. 2) 
Mock transfected control. 
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3.5. Coomasie Staining of Tandem Affinity Purification 
 
Proteins were stained with coomasie brilliant blue (Sigma) to detect cell lysis 
and protein purification from total lysate. COS7 proteins were run into SDS-PAGE gel 
and dyed (Figure 3.10). HeLa proteins were run into 2D gel electrophoresis (Figure 
3.11). 
 
                             
                             
 
Figure 3.10. Coomasie staining of purified proteins from COS7 cells. M: marker 1) 
Mock Transfection   2) 5 µl of total lysate pCTAP-A-NEU1 transfection 
3) 10 µl SEB (Streptavidin Elution Buffer) with eluted proteins with 
tagged Neu1 4) 10 µl CEB (Calmodulin Elution Buffer) with eluted 
proteins with tagged Neu1. 5) Mock transfection  6) 5 µl total lysate 
pCTAP-B-NEU4 transfection 7) 10 µl SEB with eluted proteins 8) 10 µl 
CEB with eluted proteins. Protein amount loaded on SDS-PAGE was 
determined according to Agilent; TAP kit manufacture's 
recommendations. 
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Figure 3.11 Purified HeLa proteins  2D-PAGE 
 
3.6. BSA Standard Curve 
 
We prepared standard curve which shows proportion between absorbance (595 
nm) and protein density using control BSA samples (Figure 3.12). All protein density 
calculations were done using standart curve after measurement absorbance at 595 nm. 
 
 
 
Figure 3.12. BSA standart curve 
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3.7. MS/MS  results 
Dr.Tarık Baykal (TÜBİTAK) performed MS/MS analysis of purifed proteins from pCTAP-A-
NEU1 and pCTAP-B-NEU4 transfected COS7 cells. ESI-MS/MS (ESI-QTOF) method was 
used to detect proteins. Data-independent acquisition (DIA) was used as a file format. Some 
candidate proteins were found (Table 3.1, Table 3.2). Trypsin, Calmodulin and Keratin proteins 
are contaminant in protein samples. 
 
Table 3.1. MS/MS analysis of purifed proteins in Calmodulin Elution Buffer from 
pCTAP-A-NEU1 transfected COS7 cells 
 
Accession Description mW (Da) 
pI 
(pH)
PLGS 
Score Peptides
Theoretical 
Peptides 
Coverage 
% 
P62158 CALM HUMAN Calmodulin  16826 3,9 12981 35 23 96 
P00924 ENO1 YEAST Enolase 1  46787 6,2 2041 14 28 26 
P0CG48 UBC HUMAN Polyubiquitin C  76991 7,8 1601 9 62 21 
P16402 H13 HUMAN Histone H1 3  22336 11,5 494 5 21 14 
P04264 
K2C1 HUMAN 
Keratin type II 
cytoskeletal 1  
65998 8,3 369 7 45 9 
Q8NHM4 TRY6 HUMAN Putative trypsin 6  26522 5,8 365 3 15 8 
 
 
Table 3.2. MS/MS analysis of purified proteins in Calmodulin Elution Buffer from 
pCTAP-B-NEU4 transfected COS7 cells. 
 
Accession Description mW (Da) 
pI 
(pH)
PLGS 
Score Peptides
Theoretical 
Peptides 
Coverage 
(%) 
P00924 ENO1 YEAST Enolase 1  46787 6,2 3110 18 28 30 
P62158 CALM HUMAN Calmodulin  16826 3,9 3006 10 23 72 
P10412 H14 HUMAN Histone H1 4  21852 11,5 987 7 19 22 
P07477 TRY1 HUMAN Trypsin 1  26541 6,1 477 5 14 8 
Q8WWR8-2 
NEUR4 HUMAN 
Isoform 2 of 
Sialidase 4  
52904 7,8 259 4 31 14 
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PKL files were sent to our laboratory and we also used Mascot MS/MS Ion 
Search program on internet. Proteins were searched in Swissprot protein database as a 
human (Table 3.3 and Table 3.4) and primate (Table 3.5 and Table 3.6) protein. Some 
candidate proteins were found. Calmodulin and keratin are contaminant proteins. 
 
Table 3.3. MS/MS analysis, by Mascot program on internet, of purified proteins in  
Calmodulin Elution Buffer from pCTAP-A-NEU1 transfected COS7 cells 
as human protein. Scores > 32 indicate identity or extensive homology. 
 
Description Protein Name Score 
CALM_HUMAN Calmodulin 358 
K2C1_HUMAN Keratin, Type II cytoskeletal 142 
NEUR1_HUMAN Sialidase-1 54 
K1C9_HUMAN Keratin, Type I cytoskeletal 53 
ACTBL_HUMAN Beta-actin-like protein 2 46 
K1C10_HUMAN Keratin, Type I cytoskeletal 43 
H12_HUMAN Histone H1.2 34 
FRM4B_HUMAN FERM domain-containing protein 4B 23 
PLAP_HUMAN Phospholipase A-2 activating protein 21 
 
 
Table 3.4. MS/MS analysis, by Mascot program, of purified proteins in Calmodulin 
Elution Buffer from pCTAP-B-NEU4 transfected COS7 cells as human 
protein. Scores > 33 indicate identity or extensive homology. 
 
Description Protein Name Score 
CALM_HUMAN Calmodulin 100 
H12_HUMAN Histone H1.2 87 
K2C1_HUMAN Keratin, type II cytoskeletal 71 
IL4_HUMAN Interleukin 4 23 
WNT3_HUMAN Proto-oncogene Wnt-3 22 
K1C10_HUMAN Keratin, type I cytoskeletal 18 
AT11C_HUMAN Probable phospholipid-transporting ATPase 13 
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Table 3.5. MS/MS analysis, by Mascot program, of purified proteins in Calmodulin 
Elution Buffer from pCTAP-A-NEU1 transfected COS7 cells as primate 
protein. Scores > 33 indicate identity or extensive homology. 
 
Description Protein Name Score 
CALM_HUMAN Calmodulin 332 
K2C1_HUMAN Keratin, Type II cytoskeletal 143 
NEUR1_HUMAN Sialidase-1 54 
K1C9_HUMAN Keratin, Type I cytoskeletal 47 
ACTBL_HUMAN Beta-actin-like protein 2 46 
K1C10_HUMAN Keratin, Type I cytoskeletal 35 
ZMY19_HUMAN Zinc finger MYND domain-containing protein 33 
FRM4B_HUMAN FERM domain-containing protein 4B 23 
 
 
Table 3.6. MS/MS analysis, by Mascot program, of purified proteins in Calmodulin 
Elution Buffer from pCTAP-B-NEU4 transfected COS7 cells as primate 
protein. Scores > 33 indicate identity or extensive homology. 
 
Description Protein Name Score 
CALM_HUMAN Calmodulin 96 
H12_HUMAN Histone H1.2 86 
K2C1_HUMAN Keratin, type II cytoskeletal 70 
ZMY19_HUMAN Zinc Finger MYND domain-containing protein 34 
IL4_HUMAN Interleukin-4 23 
K1C10_HUMAN Keratin, type I cytoskeletal 18 
AT11C_HUMAN Probable phospholipid-transporting ATPase 13 
 
Prof. Dr. Talat Yalçın performed (IYTE Mass Spectrometry Laboratory) MS/MS 
analysis of purified proteins from pCTAP-B-NEU4 transfected HeLa cells. MALDI-
TOF/TOF system was used to detect proteins. 4 significant MS peaks were chosen and 
MS/MS analyses were performed. MS/MS results were searched in Swissport protein 
database by using Mascot Search Program. We found some high score protein in human 
database. Also we saw same proteins when we searched MS/MS results in all 
organisms. High score proteins were highlighted in tables (Table 3.7, Table 3.8, Table 
3.9 and Table 3.10) and scores of proteins were given under tables (Figure 3.13, Figure 
3.14, Figure 3.15, and Figure 3.16). 
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Table 3.7. MALDI-TOF/TOF (MS/MS) results of purified HeLa proteins from pCTAP 
B-NEU4 transfection. 
 
CND3_HUMAN Condensin complex subunit 3 
PRP31_HUMAN U4/U6 small nuclear ribonucleoprotein 
TGFR2_HUMAN TGF-beta receptor 
TITIN_HUMAN Titin 
RB6I2_HUMAN ELKS/Rab6-interacting/CAST family member 1 
TMM70_HUMAN Transmembrane protein 70, mitochondrial 
GCST_HUMAN Aminomethyltransferase, mitochondrial 
CP2J2_HUMAN Cytochrome  P450 2J2 
PRO3_HUMAN Profilin-3 
SYNE2_HUMAN Nesprin-2 
 
 
 
Figure 3.13. Protein scores of the MS/MS results of Table 3.5 
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Table 3.8. MALDI-TOF/TOF (MS/MS) results of purified HeLa proteins from pCTAP  
B-NEU4 transfection. 
 
Description Protein Name 
CND3_HUMAN Condensin complex subunit 3 
CG0B3_HUMAN Uncharacterized protein c7orf63 
GNN_HUMAN Tetratricopeptide repeat protein GNN 
TMM70_HUMAN Transmembrane protein 70, mitochondrial 
MACF1_HUMAN Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 
CP2J2_HUMAN Cytochrome P450 2J2 
SESN2_HUMAN Sestrin-2 
FOXN4_HUMAN Forkhead box protein N4 
TRIO_HUMAN Triple function domain protein 
TGFR2_HUMAN TGF-beta receptor type-2 
 
 
 
Figure 3.14. Protein scores of the MS/MS results of Table 3.6 
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Table 3.9. MALDI-TOF/TOF (MS/MS) results of purified HeLa proteins from pCTAP 
B-NEU4 transfection. 
 
Description Protein Name 
NMD3A_HUMAN Glutamate (NMDA) receptor subunit 3A 
TRM44_HUMAN Probable tRNA (uracil-O(2)-) methyltransferase 
CCD87_HUMAN Coiled-coil domain containing protein 87 
T3HPD_HUMAN Trans-L-3-hydroxyproline dehydratase 
NFX1_HUMAN Transcriptional repressor NF-X1 
KDM8_HUMAN Lysine-specific demethylase 8 
SHSA8_HUMAN Putative protein shisa-8 
LM07_HUMAN LIM domain only protein 7 
CHST7_HUMAN Carbohydrate sulfotransferase 7 
CP21A_HUMAN Steroid 21-hydroxylase 
 
 
 
Figure 3.15. Protein scores of the MS/MS results of Table 3.7 
 
 
 
 
33 
 
Table 3.10. MALDI-TOF/TOF (MS/MS) results of purified HeLa proteins from 
pCTAP-B-NEU4 transfection. 
 
Description Protein Name 
GIMA2_HUMAN GTPase IMAP family member 2 
RP25L_HUMAN Ribonuclease P protein subunit p25-like protein 
 
 
Figure 3.16. Protein scores of the MS/MS results of Table 3.8 
 
 
 
 
 
 
 
 
 
 
34 
 
CHAPTER 4 
 
DISCUSSION 
 
Sialidases remove sialic acid residues from substrates such as glycoproteins, 
gangliosides and glycolipids. They are involved in several metabolic pathways and may 
initiate signal transduction removing sialic acid residues from receptors. 
Sialidases work in different conditions and localize different regions of cells. For 
example Neu1 makes complex with beta-galactosidase and cathepsin A enzyme in 
lysosomes. If dissociation occurs in protein complex, sialidase Neu1 loses its enzymatic 
activity causing lysosomal storage disease "sialidosis". However, proteins associated 
with other sialidases remain unknown. Therefore, in this study we aimed to tag Neu4 
and Neu1 sialidase using Calmodulin Binding Peptide and Streptavidin Binding Peptide 
and elute proteins interacted with sialidase Neu4 and Neu1 and identify associated 
proteins by using mass spectrometry. 
MS/MS data shows that there are candidate proteins which may interact sialidase 
Neu4 and Neu1. We also found that nuclear proteins are in protein composition which 
eluted in Calmodulin Elution Buffer, but most of these proteins' scores including 
nucleus proteins are too low to find significant associated protein. Surprisingly we did 
not see cathepsin A and beta-galactosidase protein in tagged Neu1 protein composition. 
The reason of this situation that probably protein interaction was not strong with tagged 
protein. 
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CHAPTER 5 
 
CONCLUSION 
 
In this study, sialidase Neu4 and Neu1 associated proteins were analysed by 
using tandem affinity purification and MS/MS methods. In TUBITAK-MAM, PGLS 
database was searched after ESI MS/MS analysis of purified proteins from pCTAP-A-
NEU1 and PCTAP-B-NEU4 transfected COS7 cells. We found calmodulin, keratin, 
polyubiqutinin C, histone 1.3 and trypsin in calmodulin elution buffer of pCTAP-A-
NEU1 transfected COS7 cells. We found isoform 2 of Neu4, trypsin, histone 1.4, 
calmodulin in calmodulin elution buffer of pCTAP-B-NEU4 transfected COS7 cells. 
Yeast enolase was control protein. Keratin and calmodulin were detected as major 
contaminants.   
Primate and Human database of Swissprot were searched for COS7 proteins 
purified from PCTAP-A-NEU1 and pCTAP-B-NEU4 transfection by using "PKL" files 
on Mascot. We have found sialidase-1, calmodulin, keratin, beta-actin like protein 2, 
histon 1.2, FERM domain containing protein, phospholipase -2 activating protein in 
calmodulin elution buffer of pCTAP-A-NEU1 transfected COS7 cells with higher score. 
We also detected calmodulin, histon 1.2, keratin, interleukin 4, proto-oncogene WNT3, 
probable phospholipid transporting ATPase IG proteins in calmodulin elution buffer of 
pCTAP-B-NEU4 transfected COS7 cells. Keratin and calmodulin were detected as 
major contaminants. Primate database results were the same as Human database except 
zinc finger MYND domain containing protein 19. Also this protein was found in both of 
calmodulin elution buffer of pCTAP-A-NEU1 and pCTAP-B-NEU4 transfected COS7 
cells sample. 
 IYTE Mass Spetrometry Laboratory performed MALDI-TOF-TOF analysis for 
purified HeLa proteins expressed from pCTAP-B-NEU4. We detected condensin 
complex subunit 3, GTPase ITAP family member 2 and glutamate (NMDA) receptor 
subunit 3A proteins as high score proteins. 
As a further study, we plan to make purification of tagged proteins from their 
specific environment like membrane, lysosome, mitochondria (organel specific 
purification). In our study we chose to tag C-terminal of sialidase Neu4 and Neu1. C-
terminal tagging might have affected protein interactions and this problem could be 
36 
 
solved by tagging N-terminal side of proteins. Other mammalian cell lines could be 
transfected with our expression vectors to compare proteins. As a future aspect, we are 
planning to analyze proteins from HeLa cell purification in TUBITAK-MAM and 
proteins from COS7 cell purification in Mass Spectrometry Laboratory in IYTE to 
compare same results in parallel. 
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